New Hampshire · 2026 Regular Session · Bill

HB 1809: establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes.

Did not advance Last action May 7, 2026: Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026; SJ 11

Plain-language summary

HB 1809 is a bill introduced in the New Hampshire House on December 18, 2025. According to its official title, it concerns: establishing a medical psilocybin advisory board to assess the advantages and disadvantages of the use of psilocybin for therapeutic purposes. Primary sponsor: Buzz Scherr (Democratic). It lists 5 additional sponsors. Most recent recorded action (May 7, 2026): Inexpedient to Legislate, MA, VV === BILL KILLED ===; 05/07/2026; SJ 11.

Sponsors

Primary sponsor: Buzz Scherr (Democratic). 5 co-sponsors.